These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8913505)
1. Evaluation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. Hashimoto Y; Kagechika H; Kawachi E; Fukasawa H; Saito G; Shudo K Biol Pharm Bull; 1996 Oct; 19(10):1322-8. PubMed ID: 8913505 [TBL] [Abstract][Full Text] [Related]
2. Correlation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. Hashimoto Y; Kagechika H; Kawachi E; Fukasawa H; Saito G; Shudo K J Cancer Res Clin Oncol; 1995; 121(11):696-8. PubMed ID: 7593136 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells. Shibakura M; Koyama T; Saito T; Shudo K; Miyasaka N; Kamiyama R; Hirosawa S Blood; 1997 Aug; 90(4):1545-51. PubMed ID: 9269772 [TBL] [Abstract][Full Text] [Related]
4. [Binding activity of retinoids with recombinant human retinoic acid receptor RAR alpha]. Cao X; Han R Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):193-5. PubMed ID: 10921005 [TBL] [Abstract][Full Text] [Related]
5. The prevention of adipose differentiation of 3T3-L1 cells caused by retinoic acid is elicited through retinoic acid receptor alpha. Kamei Y; Kawada T; Mizukami J; Sugimoto E Life Sci; 1994; 55(16):PL307-12. PubMed ID: 7934625 [TBL] [Abstract][Full Text] [Related]
6. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271 [TBL] [Abstract][Full Text] [Related]
7. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma. Meister B; Fink FM; Hittmair A; Marth C; Widschwendter M Anticancer Res; 1998; 18(3A):1777-86. PubMed ID: 9673404 [TBL] [Abstract][Full Text] [Related]
9. Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulation. Agadir A; Cornic M; Jérôme M; Menot ML; Cambier N; Gaub MP; Gourmel B; Lefebvre P; Degos L; Chomienne C Biochem Biophys Res Commun; 1995 Aug; 213(1):112-22. PubMed ID: 7639724 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993 [TBL] [Abstract][Full Text] [Related]
11. Retinoids differentially regulate the proliferation of colon cancer cell lines. Stewart LV; Thomas ML Exp Cell Res; 1997 Jun; 233(2):321-9. PubMed ID: 9194494 [TBL] [Abstract][Full Text] [Related]
12. Syntheses and structure-activity relationships of 5,6,7, 8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor alpha agonistic activity. Kikuchi K; Hibi S; Yoshimura H; Tokuhara N; Tai K; Hida T; Yamauchi T; Nagai M J Med Chem; 2000 Feb; 43(3):409-19. PubMed ID: 10669568 [TBL] [Abstract][Full Text] [Related]
13. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843 [TBL] [Abstract][Full Text] [Related]
14. Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring. Eyrolles L; Kagechika H; Kawachi E; Fukasawa H; Iijima T; Matsushima Y; Hashimoto Y; Shudo K J Med Chem; 1994 May; 37(10):1508-17. PubMed ID: 8182710 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. Charpentier B; Bernardon JM; Eustache J; Millois C; Martin B; Michel S; Shroot B J Med Chem; 1995 Dec; 38(26):4993-5006. PubMed ID: 8544175 [TBL] [Abstract][Full Text] [Related]
16. Design and stereoselective synthesis of retinoids with ferrocene or N-butylcarbazole pharmacophores that induce post-differentiation apoptosis in acute promyelocytic leukemia cells. Ivanova D; Gronemeyer H; de Lera AR ChemMedChem; 2011 Aug; 6(8):1518-29. PubMed ID: 21506276 [TBL] [Abstract][Full Text] [Related]
17. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity. Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153 [TBL] [Abstract][Full Text] [Related]
18. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulant effects of synthetic retinoids and activated vitamin D3. Koyama T; Hirosawa S Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451 [TBL] [Abstract][Full Text] [Related]
20. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]